Acute non‐heparin‐induced thrombocytopenia during hemodiafiltration in a patient with multiple myeloma

Abstract

Key Clinical Message This report demonstrates that not only heparin‐induced thrombocytopenia, but also hemodialysis conditions (platelet activation due to hemodiafiltration and heparin underdosing) may markedly reduce the platelet count and cause clotting in the hemodialysis circuit in patients in a hypercoagulable state. The clot prevention effects of bortezomib are therefore of great importance.

Keywords

• bortezomib
• hemodiafiltration
• hemodialysis
• heparin‐induced thrombocytopenia
• platelet aggregation